Global Chemotherapy Induced Peripheral Neuropathy Market
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
January 23, 2024 02:38 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
Global Diabetic Neuropathy Market
Global Diabetic Neuropathy Market Report 2022: Increasing Worldwide Incidence of Diabetes Bodes Well for Sector
November 07, 2022 05:53 ET | Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetic Neuropathy Market, By Disorder, By Distribution Channel & By Region- Forecast and Analysis 2022-2028" report has been added to ...
22157.jpg
Global Peripheral Neuropathy Market Report 2022: Strategic Insight and Analysis of Key Drivers, Market Factors & Players
October 25, 2022 06:33 ET | Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Peripheral Neuropathy Treatment Market
Peripheral Neuropathy Treatment Market Report 2022: Featuring Abbott, Eli Lilly, Pfizer, NeuroBo, Teva & Others
September 23, 2022 06:53 ET | Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market, by Indication, by Treatment and Non-Pharmacological Therapies, by End-user, and by Region - Size, Share,...
Global Chemotherapy Induced Peripheral Neuropathy Market
Chemotherapy Induced Peripheral Neuropathy Market 2028: Emerging Markets in Developing Countries Present Opportunities
July 14, 2022 06:33 ET | Research and Markets
Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel" report...
Global Chemotherapy-Induced Peripheral Neuropathy Market
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Cross $1.52 Billion by 2030 - What Are the Most Investment-Attractive Products, Segments, Applications, and Areas?
March 15, 2022 05:08 ET | Research and Markets
Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added to...